Basic HTML Version
Annual Report 2013
KPJ HEALTHCARE BERHAD
160
Issue of shares
During the nancial year, the Company increased its issued and paid-up share capital from RM323,091,000 to RM490,955,000 as follows:
(a) RM4,224,000 through the issuance of 8,448,000 ordinary shares of RM0.50 each by way of the conversion of warrants at an exercise price
of RM1.70 per share.
(b) RM163,640,000 through the issuance of 327,280,000 bonus shares of RM0.50 each.
The new ordinary shares issued during the nancial year rank pari passu in all respects with the existing ordinary shares of the Company.
Further details on change in the share capital during and subsequent to the nancial year and up to the date of this report are set out in Note 30
to the nancial statements.
Directors
The names of the directors of the Company in of ce since the date of the last report and at the date of this report are:
Dato’ Kamaruzzaman bin Abu Kassim
(Chairman)
Amiruddin bin Abdul Satar
(Managing Director)
Datin Paduka Siti Sa’diah Sh Bakir
Datuk Azzat bin Kamaludin
Zainah binti Mustafa
Hj Ahamad bin Mohamad
Dr Kok Chin Leong
Dr Yoong Fook Ngian
Tan Sri Dato’ Dr Yahya bin Awang
(Appointed on 18 July 2013)
Zulki i bin Ibrahim
(Appointed on 1 January 2014)
Aminudin bin Dawam
(Appointed on 1 January 2014)
Datuk Dr Hussein bin Awang
(Resigned on 11 Jun 2013)
Hj Rozan bin Mohd Sa’at
(Resigned on 1 January 2014)
Abd Razak bin Haron
(Deceased on 13 August 2013)
In accordance with Article 96 of the Company’s Articles of Association, Amiruddin bin Abdul Satar and Datuk Azzat bin Kamaludin, retire at the
forthcoming Annual General Meeting and being eligible, offer themselves for re-election.
In accordance with Article 97 of the Company’s Articles of Association, Tan Sri Dato’ Dr Yahya bin Awang, Zulkifli bin Ibrahim and Aminudin bin
Dawam, retire at the forthcoming Annual General Meeting and being eligible, offer themselves for re-election.
Pursuant to Section 129(6) of the Companies Act, 1965, Dr Yoong Fook Ngian, who is above the age of seventy (70) retires at the forthcoming
Annual General Meeting and a resolution will be proposed for re-appointment as director and to hold of ce until the next Annual General
Meeting.
Directors’ bene ts
Neither at the end of the nancial year, nor at any time during that year, did there subsist any arrangement to which the Company was a party,
whereby the directors might acquire bene ts by means of the acquisition of shares in or debentures of the Company or any other body corporate.
Directors’
Report
(continued)